Small Cap Gainers: OG, OPRX, ANGO

Onion Global Ltd (NASDAQ:OG) breaks out to new highs. In recent press, co today announced that it will launch an ongoing event called the “LUCA Elite Club”, designed to provide “in-depth brand knowledge” to co’s key opinion consumers on how to effectively promote co’s private label and strategic brands.

OptimizeRx Corporation (NASDAQ:OPRX) appointed to join the S&P SmallCap 600, effective prior to the open on October 4. Co also announced that Edward Stelmakh, formerly CFO/COO at Otsuka America Pharmaceuticals, has been appointed as co’s CFO and COO, effective October 11. OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages.

AngioDynamics, Inc. (NASDAQ:ANGO) reported upside Q1 EPS and revs. Med Tech net sales, which include the Auryon platform, mechanical thrombectomy, and the NanoKnife irreversible electroporation platform, increased +68.0% yr/yr. Raised its guidance for FY22 revs above consensus. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.